Citation: Jw. Paxton, THE ALLOMETRIC APPROACH FOR INTERSPECIES SCALING OF PHARMACOKINETICS AND TOXICITY OF ANTICANCER DRUGS, Clinical and experimental pharmacology and physiology, 22(11), 1995, pp. 851-854
Citation: Smh. Evans et al., PLASMA-PROTEIN BINDING OF THE EXPERIMENTAL ANTITUMOR AGENT ACRIDINE-4-CARBOXAMIDE IN MAN, DOG, RAT AND RABBIT, Journal of Pharmacy and Pharmacology, 46(1), 1994, pp. 63-67
Citation: Mg. Aman et al., EFFECTS OF PHENYTOIN ON COGNITIVE-MOTOR PERFORMANCE IN CHILDREN AS A FUNCTION OF DRUG CONCENTRATION, SEIZURE TYPE, AND TIME OF MEDICATION, Epilepsia, 35(1), 1994, pp. 172-180
Authors:
PAXTON JW
YOUNG D
EVANS SMH
ROBERTSON IGC
KESTELL P
Citation: Jw. Paxton et al., TUMOR PROFILE OF N-[2-(DIMETHYLAMINO)ETHYL]ACRIDINE-4-CARBOXAMIDE AFTER INTRAPERITONEAL ADMINISTRATION IN THE MOUSE, Cancer chemotherapy and pharmacology, 32(4), 1993, pp. 320-322
Citation: Jw. Paxton et al., PHARMACOKINETICS OF ACRIDINE-4-CARBOXAMIDE IN THE RAT, WITH EXTRAPOLATION TO HUMANS, Cancer chemotherapy and pharmacology, 32(4), 1993, pp. 323-325
Authors:
ROBERTSON IGC
PALMER BD
PAXTON JW
BLAND TJ
Citation: Igc. Robertson et al., METABOLISM OF THE EXPERIMENTAL ANTITUMOR AGENT ACRIDINE CARBOXAMIDE IN THE MOUSE, Drug metabolism and disposition, 21(3), 1993, pp. 530-536
Authors:
SCHLEMPER B
SIEGERS DJ
PAXTON JW
ROBERTSON IGC
Citation: B. Schlemper et al., RAT HEPATOCYTE-MEDIATED METABOLISM OF THE EXPERIMENTAL ANTITUMOR AGENT N-[2'-(DIMETHYLAMINO)ETHYL]ACRIDINE-4-CARBOXAMIDE, Xenobiotica, 23(4), 1993, pp. 361-371